Inpatient ward

The inpatient ward provides space for hospitalization of patients with blood formation disorders for the purpose of diagnosing these conditions and especially their treatment. In cooperation with the complement of UHKT laboratories, we perform highly specialized examinations including the latest molecular genetic and cytogenetic methods. Treatment is performed in accordance with current national and international treatment protocols using standard and highly innovative medicinal products.

The spectrum of our patients consists mainly of:

• Patients with highly malignant hematological malignancies including acute myeloid leukemias (AML), acute lymphoblastic leukemias (ALL), blast phases of chronic myeloid leukemia (CML) and advanced stages of myelodysplastic syndrome (MDS)
• Patients with early and late complications after blood-forming cell transplantation
• Patients with congenital or acquired blood coagulation disorders including therapy and observation of these patients after surgical or dental procedures
• Patients with aplastic anemia or blood formation suppression from other causes, patients with severe forms of hemolytic anemias and patients with rare diseases of red blood cells

Treatment of patients on the inpatient ward is regularly consulted within working groups for individual hematological diagnoses, which are established within UHKT, such as the working group for acute myeloid leukemia, or the working group for myelodysplastic syndrome. Members or leaders of these groups often participate personally in patient therapy.

International clinical and smaller academic studies also regularly take place on the inpatient ward, which allows hospitalized patients access to the latest experimental medicinal products or therapeutic procedures.